Uniplan Investment Counsel’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.16M | Sell |
62,953
-5,839
| -8% | -$664K | 0.72% | 38 |
|
|
2025
Q1 | $7.23M | Buy |
68,792
+637
| +0.9% | +$67K | 0.7% | 37 |
|
|
2024
Q4 | $7.3M | Buy |
68,155
+15,051
| +28% | +$1.61M | 0.68% | 39 |
|
|
2024
Q3 | $5.32M | Buy |
53,104
+3,487
| +7% | +$349K | 0.46% | 54 |
|
|
2024
Q2 | $4.18M | Buy |
49,617
+8,416
| +20% | +$709K | 0.38% | 65 |
|
|
2024
Q1 | $3.01M | Buy |
+41,201
| New | +$3.01M | 0.24% | 84 |
|